Movatterモバイル変換


[0]ホーム

URL:


EP1077760B1 - Methods and apparatus for particle formation - Google Patents

Methods and apparatus for particle formation
Download PDF

Info

Publication number
EP1077760B1
EP1077760B1EP99919410AEP99919410AEP1077760B1EP 1077760 B1EP1077760 B1EP 1077760B1EP 99919410 AEP99919410 AEP 99919410AEP 99919410 AEP99919410 AEP 99919410AEP 1077760 B1EP1077760 B1EP 1077760B1
Authority
EP
European Patent Office
Prior art keywords
fluid
solution
vehicle
supercritical
vessel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP99919410A
Other languages
German (de)
French (fr)
Other versions
EP1077760A1 (en
Inventor
Mazen Hermiz Hanna
Peter York
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nektar Therapeutics UK Ltd
Original Assignee
Bradford Particle Design Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bradford Particle Design LtdfiledCriticalBradford Particle Design Ltd
Publication of EP1077760A1publicationCriticalpatent/EP1077760A1/en
Application grantedgrantedCritical
Publication of EP1077760B1publicationCriticalpatent/EP1077760B1/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

The invention provides a method for forming particles of a target substance (26), involving: (a) preparing a solution or suspension of the substance in a vehicle (21) which is or includes either a near-critical fluid (21) or a first supercritical fluid; (b) introducing the solution or suspension into a particle formation vessel (32); and (c) contacting the solution or suspension, in the particle formation vessel, with a second super-critical fluid, under conditions which allow the second supercritical fluid to cause precipitation of particles of the target substance from the solution or suspension; wherein the second supercritical fluid is miscible or substantially miscible with the vehicle and is a fluid in which the target substance is insoluble or substantially insoluble. Also provided is apparatus for use in carrying out an embodiment of the method, including a particle formation vessel and means for controlling the temperature and pressure inside it; a fluid mixing vessel and means for controlling the temperature and pressure inside it; first fluid inlet means for introducing into the fluid mixing vessel a vehicle and a solution of a target substance in a primary solvent, so as to form in the fluid mixing vessel a solution of the substance and the primary solvent in the vehicle; and second fluid inlet means for introducing the solution thus formed, preferably together with a second supercritical fluid, into the particle formation vessel. The invention also provides a particulate product formed using the method.

Description

Claims (15)

  1. Apparatus for use in carrying out a method according to claim 12 or claim 13,the apparatus including a particle formation vessel; means for controlling thetemperature and pressure in the particle formation vessel at desired levels; a fluid mixingvessel; means for controlling the temperature and pressure in the fluid mixing vessel atdesired levels; first fluid inlet means for introducing into the fluid mixing vessel avehicle and a primary solution of a target substance in a primary solvent, so as to form inthe fluid mixing vessel a target solution of the target substance and the primary solventin the vehicle; and second fluid inlet means for introducing the target solution thusformed, preferably together with a second supercritical fluid, into the particle formationvessel;
    wherein the first fluid inlet means allows both the primary solution and the vehicle toenter the fluid mixing vessel at the same or substantially the same point, which is alsothe same as, or substantially the same as, the point where they meet, and wherein thefirst fluid inlet means also allows the vehicle to disperse the primary solution at orsubstantially at the point where the fluids enter the fluid mixing vessel.
EP99919410A1998-05-151999-04-29Methods and apparatus for particle formationExpired - LifetimeEP1077760B1 (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
GBGB9810559.6AGB9810559D0 (en)1998-05-151998-05-15Method and apparatus for particle formation
GB98105591998-05-15
PCT/GB1999/001337WO1999059710A1 (en)1998-05-151999-04-29Methods and apparatus for particle formation

Publications (2)

Publication NumberPublication Date
EP1077760A1 EP1077760A1 (en)2001-02-28
EP1077760B1true EP1077760B1 (en)2003-02-19

Family

ID=10832197

Family Applications (1)

Application NumberTitlePriority DateFiling Date
EP99919410AExpired - LifetimeEP1077760B1 (en)1998-05-151999-04-29Methods and apparatus for particle formation

Country Status (12)

CountryLink
US (2)US6576262B1 (en)
EP (1)EP1077760B1 (en)
JP (1)JP2002515324A (en)
AT (1)ATE232754T1 (en)
AU (1)AU751106B2 (en)
CA (1)CA2329902C (en)
DE (1)DE69905460T2 (en)
DK (1)DK1077760T3 (en)
ES (1)ES2193700T3 (en)
GB (1)GB9810559D0 (en)
MX (1)MXPA00011185A (en)
WO (1)WO1999059710A1 (en)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB9703673D0 (en)*1997-02-211997-04-09Bradford Particle Design LtdMethod and apparatus for the formation of particles
GB9810559D0 (en)*1998-05-151998-07-15Bradford Particle Design LtdMethod and apparatus for particle formation
US6630121B1 (en)1999-06-092003-10-07The Regents Of The University Of ColoradoSupercritical fluid-assisted nebulization and bubble drying
GB9915975D0 (en)1999-07-071999-09-08Bradford Particle Design LtdMethod for the formation of particles
EP1090894A1 (en)*1999-10-062001-04-11Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.Process for making fine particles of explosives
GB9927011D0 (en)1999-11-162000-01-12Advanced Phytonics LtdMethod for the production of particles
US6761909B1 (en)1999-12-212004-07-13Rxkinetix, Inc.Particulate insulin-containing products and method of manufacture
WO2001045731A1 (en)1999-12-212001-06-28Rxkinetix, Inc.Particulate drug-containing products and method of manufacture
FR2815540B1 (en)*2000-10-192005-06-10Separex Sa PROCESS FOR MANUFACTURING VERY FINE PARTICLES COMPRISING A PRINCIPLE INSERTED IN A HOST MOLECULE
GB0027357D0 (en)2000-11-092000-12-27Bradford Particle Design PlcParticle formation methods and their products
AU2002221320B2 (en)*2000-12-082006-06-15The University Of SydneySynthesis of small particles
AUPR197000A0 (en)2000-12-082001-01-11Unisearch LimitedSynthesis of small particles
GB0102075D0 (en)2001-01-262001-03-14Astrazeneca AbProcess
CN100531886C (en)*2001-02-262009-08-26多姆普Pha.R.Ma公司 Apparatus and method for forming micron and submicron particles
US20070122353A1 (en)2001-05-242007-05-31Hale Ron LDrug condensation aerosols and kits
US7090830B2 (en)2001-05-242006-08-15Alexza Pharmaceuticals, Inc.Drug condensation aerosols and kits
US7458374B2 (en)2002-05-132008-12-02Alexza Pharmaceuticals, Inc.Method and apparatus for vaporizing a compound
US7585493B2 (en)2001-05-242009-09-08Alexza Pharmaceuticals, Inc.Thin-film drug delivery article and method of use
US7766013B2 (en)2001-06-052010-08-03Alexza Pharmaceuticals, Inc.Aerosol generating method and device
GB0208742D0 (en)2002-04-172002-05-29Bradford Particle Design LtdParticulate materials
GB0117696D0 (en)*2001-07-202001-09-12Bradford Particle Design PlcParticle information
FR2830760B1 (en)2001-10-122004-06-04Pf Medicament PROCESS FOR THE PREPARATION OF AN INTERACTION COMPOUND OF ACTIVE SUBSTANCES WITH A POROUS SUPPORT BY SUPERCRITICAL FLUID
WO2003035673A1 (en)2001-10-222003-05-01Dompe S.P.A.Supercritical fluids processing: preparation of protein microparticles and their stabilisation
US7574930B2 (en)*2002-02-152009-08-18Implant Sciences CorporationTrace chemical sensing
US20050163725A1 (en)*2002-03-202005-07-28Blizzard Charles D.Method for administration of growth hormone via pulmonary delivery
US7008644B2 (en)*2002-03-202006-03-07Advanced Inhalation Research, Inc.Method and apparatus for producing dry particles
JP2005521695A (en)*2002-03-202005-07-21アドバンスト インハレーション リサーチ,インコーポレイテッド Method of administering growth hormone by pulmonary delivery
CA2482272C (en)*2002-04-122011-08-16Feyecon Development & Implementation B.V.Process for small particle formation
US7582284B2 (en)2002-04-172009-09-01Nektar TherapeuticsParticulate materials
GB0216562D0 (en)*2002-04-252002-08-28Bradford Particle Design LtdParticulate materials
US9339459B2 (en)2003-04-242016-05-17Nektar TherapeuticsParticulate materials
US20040202681A1 (en)*2002-12-192004-10-14Baxter International, Inc.Process for preparing pharmaceutical formulations using supercritical fluids
GB0229714D0 (en)*2002-12-202003-01-29Glaxo Group LtdNovel apparatus and method
FR2854079B1 (en)2003-04-252007-11-30Pf Medicament PROCESS FOR THE PREPARATION OF MOLECULAR COMPLEXES
MXPA05011343A (en)2003-05-082005-12-12Nektar Therapeutics Uk LtdParticulate materials.
JP2007516149A (en)2003-05-212007-06-21アレックザ ファーマシューティカルズ, インコーポレイテッド Method for controlling uniformity of substrate temperature, built-in heating unit and chemical supply unit using the same
US7767118B2 (en)2003-06-032010-08-03Ferro CorporationNanoparticles from supercritical fluid antisolvent process using particle growth and agglomeration retardants
WO2004110585A1 (en)*2003-06-102004-12-23Taisho Pharmaceutical Co., Ltd.Radial spherical crystallization product, process for producing the same and dry powder preparation containing the crystallization product
AU2004272077A1 (en)*2003-09-102005-03-24Map Pharmaceuticals, Inc.Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
US7540286B2 (en)2004-06-032009-06-02Alexza Pharmaceuticals, Inc.Multiple dose condensation aerosol devices and methods of forming condensation aerosols
WO2006022714A1 (en)2004-08-122006-03-02Alexza Pharmaceuticals, Inc.Aerosol drug delivery device incorporating percussively activated heat packages
US20060280027A1 (en)*2005-06-102006-12-14Battelle Memorial InstituteMethod and apparatus for mixing fluids
WO2007009164A1 (en)2005-07-152007-01-25Eiffel Technologies LimitedMethod of particle formation
US20070120281A1 (en)*2005-11-082007-05-31Boris KhusidManufacture of fine particles and nano particles and coating thereof
EP2073790B1 (en)*2006-10-062018-05-16NewSouth Innovations Pty LimitedParticle formation
EP2476412B1 (en)*2006-10-112014-03-19Crititech, Inc.Apparatus for precipitation of small medicament particles into use containers
GB0702402D0 (en)2007-02-082007-03-21Thar Pharmaceuticals IncMethod of creating crystalline substances
MX2009008582A (en)2007-02-112009-10-30Map Pharmaceuticals IncMethod of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile.
WO2008112661A2 (en)2007-03-092008-09-18Alexza Pharmaceuticals, Inc.Heating unit for use in a drug delivery device
PL2229233T3 (en)*2007-12-072020-03-31Xspray Pharma Ab (Publ)Method for the production of particles
US20100294986A1 (en)*2009-05-192010-11-25Massachusetts Institute Of TechnologySupercritical fluid facilitated particle formation in microfluidic systems
US20100298602A1 (en)*2009-05-192010-11-25Massachusetts Institute Of TechnologySystems and methods for microfluidic crystallization
WO2010151804A1 (en)*2009-06-262010-12-29Map Pharmaceuticals, Inc.Administration of dihydroergotamine mesylate particles using a metered dose inhaler
US9808030B2 (en)2011-02-112017-11-07Grain Processing CorporationSalt composition
JP6328364B2 (en)*2012-03-262018-05-23株式会社リコー Particle manufacturing method, toner, developer, and image forming apparatus
GB201402556D0 (en)2014-02-132014-04-02Crystec LtdImprovements relating to inhalable particles
EP3325456B1 (en)2015-07-222025-09-03Anavex Life Sciences Corp.Crystal form of tetra-hydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, process for its preparation, and pharmaceutical compositions containing it
JP7096771B2 (en)*2016-04-292022-07-06ザ ソリュビィリティ カンパニー オーユー Methods and devices for determining the physicochemical properties of materials
JP6569744B2 (en)*2018-01-152019-09-04株式会社リコー Method for producing particles
EP3746138A4 (en)2018-02-022021-11-03Alexza Pharmaceuticals, Inc. ELECTRIC CONDENSATION AEROSOL DEVICE
JP2020006369A (en)*2019-08-072020-01-16株式会社リコーManufacturing method of particles
FI129026B (en)2020-01-292021-05-31Nanoform Finland OySystem and method to produce particles of organic substances
GB202312252D0 (en)2023-08-102023-09-27Inhalis Therapeutics SaCrystalline compositions
GB202318661D0 (en)2023-12-062024-01-17Crystec LtdTranexamic acid compositions

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4582731A (en)*1983-09-011986-04-15Battelle Memorial InstituteSupercritical fluid molecular spray film deposition and powder formation
US4514574A (en)*1984-01-091985-04-30The Dow Chemical CompanyProcess for separating isomeric mixtures
US4737384A (en)*1985-11-011988-04-12Allied CorporationDeposition of thin films using supercritical fluids
EP0321607B1 (en)*1987-12-211993-09-22Union Carbide CorporationSupercritical fluids as diluents in liquid spray application of coatings
DE3744329A1 (en)*1987-12-281989-07-06Schwarz Pharma Gmbh METHOD FOR THE PRODUCTION OF AT LEAST ONE ACTIVE AGENT AND A TRAITER COMPRISING PREPARATION
US5066522A (en)*1988-07-141991-11-19Union Carbide Chemicals And Plastics Technology CorporationSupercritical fluids as diluents in liquid spray applications of adhesives
US5707634A (en)*1988-10-051998-01-13Pharmacia & Upjohn CompanyFinely divided solid crystalline powders via precipitation into an anti-solvent
US5232707A (en)*1989-07-101993-08-03Syntex (U.S.A.) Inc.Solvent extraction process
US5106659A (en)*1989-10-041992-04-21Nordson CorporationMethod and apparatus for spraying a liquid coating containing supercritical fluid or liquified gas
US4970093A (en)*1990-04-121990-11-13University Of Colorado FoundationChemical deposition methods using supercritical fluid solutions
DE4118230A1 (en)*1990-12-201992-06-25Bayer Ag METHOD OF ISOLATING POLYMERS FROM THEIR SOLVENTS WITH CARBON DIOXIDE-CONTAINING LIQUIDS
DE4041563A1 (en)*1990-12-221992-06-25Sanol Arznei Schwarz Gmbh METHOD FOR PRODUCING ACTIVE MICROPARTICLES FROM HYDROLYTICALLY DEGRADABLE POLYMERS
DE4117751A1 (en)*1991-05-301992-12-03Bayer Ag METHOD FOR INSULATING POLYCARBONATES
US6063910A (en)*1991-11-142000-05-16The Trustees Of Princeton UniversityPreparation of protein microparticles by supercritical fluid precipitation
US5196575A (en)*1992-02-191993-03-23Hoechst Celanese Corp.Supercritical separation of isomers of functional organic compounds at moderate conditions
US5639441A (en)*1992-03-061997-06-17Board Of Regents Of University Of ColoradoMethods for fine particle formation
US5301664A (en)*1992-03-061994-04-12Sievers Robert EMethods and apparatus for drug delivery using supercritical solutions
WO1994008599A1 (en)*1992-10-141994-04-28The Regents Of The University Of ColoradoIon-pairing of drugs for improved efficacy and delivery
JPH08503721A (en)*1992-11-021996-04-23フェロー コーポレイション Manufacturing method of coating material
DE59308043D1 (en)*1993-02-241998-02-26Sulzer Chemtech Ag Purification of salt-laden wastewater by wet oxidation under supercritical conditions
US5554382A (en)*1993-05-281996-09-10Aphios CorporationMethods and apparatus for making liposomes
GB9313642D0 (en)*1993-07-011993-08-18Glaxo Group LtdMethod and apparatus for the formation of particles
GB9313650D0 (en)*1993-07-011993-08-18Glaxo Group LtdMethod and apparatus for the formation of particles
JPH09508055A (en)*1993-11-081997-08-19ザ、ジレット、カンパニー Method of forming particles using supercritical fluid, airgel particles formed thereby, and antiperspirant containing airgel particles
US6051256A (en)*1994-03-072000-04-18Inhale Therapeutic SystemsDispersible macromolecule compositions and methods for their preparation and use
GB9413202D0 (en)*1994-06-301994-08-24Univ BradfordMethod and apparatus for the formation of particles
US5560543A (en)*1994-09-191996-10-01Board Of Regents, The University Of Texas SystemHeat-resistant broad-bandwidth liquid droplet generators
MX9504934A (en)*1994-12-121997-01-31Morton Int IncSmooth thin film powder coatings.
US5639475A (en)*1995-02-031997-06-17Eurand America, IncorporatedEffervescent microcapsules
EP0885038B1 (en)1996-03-012011-06-15The University Of KansasMethods and apparatus for particle precipitation and coating using near-critical and supercritical antisolvents
US5874029A (en)*1996-10-091999-02-23The University Of KansasMethods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
GB9703673D0 (en)*1997-02-211997-04-09Bradford Particle Design LtdMethod and apparatus for the formation of particles
GB9800936D0 (en)*1997-05-101998-03-11Univ NottinghamBiofunctional polymers
GB9810559D0 (en)*1998-05-151998-07-15Bradford Particle Design LtdMethod and apparatus for particle formation
GB9915975D0 (en)*1999-07-071999-09-08Bradford Particle Design LtdMethod for the formation of particles
US6620351B2 (en)*2000-05-242003-09-16Auburn UniversityMethod of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer
FR2815540B1 (en)*2000-10-192005-06-10Separex Sa PROCESS FOR MANUFACTURING VERY FINE PARTICLES COMPRISING A PRINCIPLE INSERTED IN A HOST MOLECULE
GB0027357D0 (en)*2000-11-092000-12-27Bradford Particle Design PlcParticle formation methods and their products
GB0117696D0 (en)*2001-07-202001-09-12Bradford Particle Design PlcParticle information
MXPA05011343A (en)*2003-05-082005-12-12Nektar Therapeutics Uk LtdParticulate materials.

Also Published As

Publication numberPublication date
CA2329902A1 (en)1999-11-25
ATE232754T1 (en)2003-03-15
GB9810559D0 (en)1998-07-15
US6576262B1 (en)2003-06-10
AU3720999A (en)1999-12-06
DK1077760T3 (en)2003-06-16
AU751106B2 (en)2002-08-08
WO1999059710A1 (en)1999-11-25
DE69905460T2 (en)2004-02-26
ES2193700T3 (en)2003-11-01
DE69905460D1 (en)2003-03-27
EP1077760A1 (en)2001-02-28
JP2002515324A (en)2002-05-28
MXPA00011185A (en)2003-05-19
CA2329902C (en)2008-07-15
US20040071783A1 (en)2004-04-15

Similar Documents

PublicationPublication DateTitle
EP1077760B1 (en)Methods and apparatus for particle formation
US7150766B2 (en)Method of particle formation
US5851453A (en)Method and apparatus for the formation of particles
US5795594A (en)Salmeterol xinafoate with controlled particle size
US20020010982A1 (en)Method and apparatus for the formation of particles
US7087197B2 (en)Particle formation
WO1998036825A1 (en)Method & apparatus for the formation of particles
AU2002314390A1 (en)Method and apparatus for preparing particles
WO2003008082A1 (en)Method and apparatus for preparing particles
US20050085409A1 (en)Particle formation
US7767118B2 (en)Nanoparticles from supercritical fluid antisolvent process using particle growth and agglomeration retardants
GB2339165A (en)Method and apparatus for particle formation using supercritical fluids
EP2204230A1 (en)Method for preparation of particles

Legal Events

DateCodeTitleDescription
PUAIPublic reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text:ORIGINAL CODE: 0009012

17PRequest for examination filed

Effective date:20001121

AKDesignated contracting states

Kind code of ref document:A1

Designated state(s):AT BE CH CY DE DK ES FI FR GB GR IE IT LI NL PT SE

Kind code of ref document:A1

Designated state(s):AT BE CH CY DE DK ES FI FR GR IE IT LI NL PT SE

17QFirst examination report despatched

Effective date:20010409

RAP1Party data changed (applicant data changed or rights of an application transferred)

Owner name:BRADFORD PARTICLE DESIGN LIMITED

GRAGDespatch of communication of intention to grant

Free format text:ORIGINAL CODE: EPIDOS AGRA

GRAGDespatch of communication of intention to grant

Free format text:ORIGINAL CODE: EPIDOS AGRA

GRAHDespatch of communication of intention to grant a patent

Free format text:ORIGINAL CODE: EPIDOS IGRA

RBVDesignated contracting states (corrected)

Designated state(s):AT BE CH CY DE DK ES FI FR GR IE IT LI NL PT SE

GRAHDespatch of communication of intention to grant a patent

Free format text:ORIGINAL CODE: EPIDOS IGRA

GRAA(expected) grant

Free format text:ORIGINAL CODE: 0009210

AKDesignated contracting states

Designated state(s):AT BE CH CY DE DK ES FI FR GR IE IT LI NL PT SE

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:GR

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20030219

Ref country code:AT

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20030219

REGReference to a national code

Ref country code:CH

Ref legal event code:EP

REGReference to a national code

Ref country code:IE

Ref legal event code:FG4D

REGReference to a national code

Ref country code:SE

Ref legal event code:TRGR

REFCorresponds to:

Ref document number:69905460

Country of ref document:DE

Date of ref document:20030327

Kind code of ref document:P

RAP2Party data changed (patent owner data changed or rights of a patent transferred)

Owner name:NEKTAR THERAPEUTICS UK LIMITED

REGReference to a national code

Ref country code:CH

Ref legal event code:NV

Representative=s name:MICHELI & CIE INGENIEURS-CONSEILS

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:CY

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20030429

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:PT

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20030519

ETFr: translation filed
REGReference to a national code

Ref country code:DK

Ref legal event code:T3

REGReference to a national code

Ref country code:ES

Ref legal event code:FG2A

Ref document number:2193700

Country of ref document:ES

Kind code of ref document:T3

PLBENo opposition filed within time limit

Free format text:ORIGINAL CODE: 0009261

STAAInformation on the status of an ep patent application or granted ep patent

Free format text:STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26NNo opposition filed

Effective date:20031120

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:FI

Payment date:20070314

Year of fee payment:9

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:NL

Payment date:20070315

Year of fee payment:9

Ref country code:IE

Payment date:20070315

Year of fee payment:9

Ref country code:DK

Payment date:20070315

Year of fee payment:9

Ref country code:CH

Payment date:20070315

Year of fee payment:9

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:SE

Payment date:20070319

Year of fee payment:9

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:BE

Payment date:20070330

Year of fee payment:9

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:ES

Payment date:20070410

Year of fee payment:9

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:IT

Payment date:20070718

Year of fee payment:9

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:FR

Payment date:20070312

Year of fee payment:9

BEREBe: lapsed

Owner name:*NEKTAR THERAPEUTICS UK LTD

Effective date:20080430

REGReference to a national code

Ref country code:CH

Ref legal event code:PL

REGReference to a national code

Ref country code:DK

Ref legal event code:EBP

EUGSe: european patent has lapsed
NLV4Nl: lapsed or anulled due to non-payment of the annual fee

Effective date:20081101

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:NL

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20081101

Ref country code:LI

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20080430

Ref country code:CH

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20080430

REGReference to a national code

Ref country code:FR

Ref legal event code:ST

Effective date:20081231

REGReference to a national code

Ref country code:IE

Ref legal event code:MM4A

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:FI

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20080429

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:BE

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20080430

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:IE

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20080429

Ref country code:FR

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20080430

Ref country code:DK

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20080430

REGReference to a national code

Ref country code:ES

Ref legal event code:FD2A

Effective date:20080430

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:ES

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20080430

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:IT

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20080429

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:SE

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20080430

REGReference to a national code

Ref country code:DE

Ref legal event code:R082

Ref document number:69905460

Country of ref document:DE

Representative=s name:MEISSNER, BOLTE & PARTNER GBR, DE

REGReference to a national code

Ref country code:FR

Ref legal event code:TP

Owner name:NEKTAR THERAPEUTICS, US

Effective date:20121026

REGReference to a national code

Ref country code:DE

Ref legal event code:R082

Ref document number:69905460

Country of ref document:DE

Representative=s name:MEISSNER BOLTE PATENTANWAELTE RECHTSANWAELTE P, DE

Effective date:20121113

Ref country code:DE

Ref legal event code:R082

Ref document number:69905460

Country of ref document:DE

Representative=s name:MEISSNER, BOLTE & PARTNER GBR, DE

Effective date:20121113

Ref country code:DE

Ref legal event code:R081

Ref document number:69905460

Country of ref document:DE

Owner name:NEKTAR THERAPEUTICS, SAN FRANCISCO, US

Free format text:FORMER OWNER: NEKTAR THERAPEUTICS UK LTD., BRADFORD, WEST YORKSHIRE, GB

Effective date:20121113

Ref country code:DE

Ref legal event code:R081

Ref document number:69905460

Country of ref document:DE

Owner name:NEKTAR THERAPEUTICS, US

Free format text:FORMER OWNER: NEKTAR THERAPEUTICS UK LTD., BRADFORD, GB

Effective date:20121113

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:DE

Payment date:20180420

Year of fee payment:20

REGReference to a national code

Ref country code:DE

Ref legal event code:R071

Ref document number:69905460

Country of ref document:DE


[8]ページ先頭

©2009-2025 Movatter.jp